The “2nd SPLC-CRS Young Scientists Meeting” will take place on January 23, 2019 (morning schedule) at the School of Medicine of the University of Santiago de Compostela, Spain.
FORMAT OF THE MEETING
- Two talks from speakers invited by the organizing society
- Short students’ oral and poster presentations
Scientific Program
08:30 h | Registration Presentations upload / posters mounting |
08:50 h | Welcome Dolores Torres (USC; SPLC-CRS President); Maria José Alonso (USC; CRS President) |
09:00 h |
Invited speaker – Marta Vives-Pi |
Young scientist session I Chairs: María Jesús Vicent (CIPF, Valencia) |
|
09:30 h | Polymeric nanocapsules as a novel tolerogenic treatment for Type 1 Diabetes - Ana Olivera Center for Research in Molecular Medicine and Chronic Diseases (CIMUS, University of Santiago de Compostela |
09:39 h | Development of in vitro dissolution tools predictive of the in vivo behaviour of pharmaceutical formulations: Candesartan in vitro-in vivo correlation (IVIVC) - Bárbara Sánchez Dengra Pharmacokinetics and Pharmaceutical Technology Area. Miguel Hernandez University |
09:48 h | Engineered albumin conjugated nanoparticles are a promising strategy to enhance FcRn-mediated delivery across intestinal barriers – Claudia Azevedo i3S Instituto de Investigação e Inovação em Saúde. Universidade do Porto |
09:57 h | Nanoencapsulated Bevacizumab Inhibits Glioblastoma Vascularization via Intratumoral VEGF Trapping – Flávia Sousa i3S Instituto de Investigação e Inovação em Saúde. Universidade do Porto |
10:06 h | A nanotechnological approach to improve the therapeutic efficacy of cytotoxic agents against melanoma – Jacinta Pinho Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa |
10:15 h | Evaluation of the immunotoxicological properties of PLA nanoparticles– Jessica da Silva Faculty of Farmacy. University od Coimbra |
10:24 h | Casein nanoparticles as effective vehicles for enhancing the oral bioavailability of resveratrol – Jorge Morales Gracia Department of Chemistry and Pharmaceutical Technology, University of Navarra |
10:33 h | Design of an anti IGFR1 polymer-antibody conjugate in combination with Abiraterone for the treatment of Castration-Resistant Prostate Cancer (CRPC) – Katia Maso Polymer Therapeutics Lab, Centro de investigación Príncipe Felipe (CIPF), Valencia |
10:42 h | Combination of cardiomyocytes derived from human induced pluripotent stem cells with biomaterials restores cardiac function in infarcted mice – Laura Saludas Echauri Department of Chemistry and Pharmaceutical Technology, University of Navarra |
11:00 h | Coffee-break/ Posters Viewing |
11:30 h |
Invited speaker- João F. Mano |
Young scientist session II Chairs: Helena Florindo (U Lisboa) |
|
12:00 h | Nanotechnology-based approach for the delivery of glycoconjugate vaccines - Maruthi Prasanna Center for Research in Molecular Medicine and Chronic Diseases (CIMUS, University of Santiago de Compostela |
12:09 h | Rational development and preclinical assessment of bio-inspired Protein-Metal Nanosystems as oral delivery carrier – Matilde Durán Lobato Center for Research in Molecular Medicine and Chronic Diseases (CIMUS, University of Santiago de Compostela |
12:18 h | Control of Loading and Polarized Orientation of Antibodies onto Gold Nanoparticles – Mireya López Borrajo Institut Català de Nanociència i Nanotecnologia (ICN2), CSIC (Barelona) |
12:27 h | Impact of PEG coating in the distribution and retention of PLGA nanoparticles in colorectal tissues – Rute Nunes I3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto |
12:36 h | Multimodal nanoemulsions for whole-body imaging in metastatic cancer – Sandra Diez Villares Nano-Oncology Unit, Translational Medical Oncology Group (ONCOMET). Health Research Institute of Santiago de Compostela (IDIS) and CIBERONC, Santiago de Compostela |
12:45 h |
Combination of polymeric nanoparticles and alginate cryogel towards the development of an in situ cancer vaccine – Tomas Ramos |
13:00 h | Award Ceremony for the best oral and poster presentations |
13:15 h | SPLC-CRS General Assembly |